VAV 1 and BAFF , via NF κB pathway, are genetic risk factors for myasthenia gravis-Reference-Cited by-同舟云学术

VAV 1 and BAFF , via NF κB pathway, are genetic risk factors for myasthenia gravis

Published:2014-04-11 Issue:5 Volume:1 Page:329-339
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Avidan Nili¹,Panse Rozen²,Harbo Hanne F.³⁴,Bernasconi Pia⁵,Poulas Konstantinos⁶,Ginzburg Elizabeta¹,Cavalcante Paola⁵,Colleoni Lara⁵,Baggi Fulvio⁵,Antozzi Carlo⁵,Truffault Frédérique²,Horn‐Saban Shirley⁷,Pöschel Simone⁸⁹,Zagoriti Zoi⁶,Maniaol Angelina³,Lie Benedicte A.⁴¹⁰,Bernard Isabelle¹¹¹²,Saoudi Abdelhadi¹¹¹²,Illes Zsolt¹³¹⁴,Casasnovas Pons Carlos¹⁵,Melms Arthur⁸⁹,Tzartos Socrates⁶¹⁶,Willcox Nicholas¹⁷,Kostera‐Pruszczyk Anna¹⁸,Tallaksen Chantal³⁴,Mantegazza Renato⁵,Berrih‐Aknin Sonia²,Miller Ariel¹¹⁹

Affiliation:

1. Pharmacogenetics and Translational Genetics Center The Rappaport Faculty of Medicine and Research Institute Technion‐Israel Institute of Technology Haifa Israel

2. Research Unit (INSERM U974/CNRS UMR7215//UPMC UM76/AIM) – Institute of Myology Pitié‐Salpêtrière Paris France

3. Department of Neurology Oslo University Hospital Ullevål Norway

4. Institute of Clinical Medicine University of Oslo Oslo Norway

5. Department of Neurology IV Neuromuscular Diseases and Neuroimmunology Fondazione Istituto Neurologico Carlo Besta (INNCB) Milan Italy

6. Department of Pharmacy University of Patras Patras Greece

7. Department of Biological Services Weizmann Institute of Science Rehovot Israel

8. Department of Neurology Tübingen University Medical Center Tubingen Germany

9. Neurologische Klinik Universitätsklinikum Erlangen Erlangen Germany

10. Department of Medical Genetics Oslo University Hospital Ullevål Norway

11. INSERM, U1043 Toulouse F‐31300 France

12. Centre National de la Recherche Scientifique, U5282 Toulouse F‐31300 France

13. Department of Neurology University of Pecs Pecs Hungary

14. Department of Neurology Odense University Hospital University of Southern Denmark Odense Denmark

15. Hospital Universitari de Bellvitge L'Hospitalet de Llobregat Barcelona Spain

16. Hellenic Pasteur Institute Athens Greece

17. Clinical Neurology Weatherall Institute for Molecular Medicine University of Oxford Oxford United Kingdom

18. Department of Neurology Medical University of Warsaw Warsaw Poland

19. Division of Neuroimmunology Carmel Medical Center Haifa Israel

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51

Reference52 articles.

1. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

2. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value

3. A systematic review of population based epidemiological studies in Myasthenia Gravis

4. A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C

5. Risk for myasthenia gravis maps to a151Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases;Trends in Immunology;2024-08

2. Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation;Cellular and Molecular Life Sciences;2024-04-02

3. Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis;Genes;2022-04-15

4. Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis;Cell Discovery;2021-09-14

5. Human leukocyte antigens (HLA) association with myasthenia gravis (MG) and its myasthenia manifestations in Algerian patients;Meta Gene;2021-09